Skip to main content

Advertisement

Log in

Secondary Metabolites of Oplopanax elatus: Possibilities for Standardization of a Multiphytoadaptogen for Preventive Oncology

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

An herbal formulation of a multiphytoadaptogen (MPA) developed at the N. N. Blokhin Cancer Center and containing phytocomponents from Oplopanax elatus Nakai has been studied in preclinical and clinical trials for preventive oncology. Secondary metabolites were identified in the extract of rhizomes and roots of O. elatus and in the MPA pharmaceutical composition using high performance liquid chromatography-mass spectrometry (HPLC-MS/MS). Compounds identical to ginsenosides Rd and Re (tetracyclic triterpene saponins from Panax ginseng) and araloside C and stipuleanoside R2 (pentacyclic triterpene saponins, oleanolic acid derivatives, from Aralia mandshurica) were identified in the MPA and in the extract of rhizomes and roots of O. elatus. The spectra of biological activity of ginsenosides Rd and Re, araloside C, and stipuleanoside R2 were analyzed in silico using the PASS computer program. According to published data and in silico analysis, the activities of ginsenosides Rd and Re, araloside C, and stipuleanoside R2 correspond to properties previously confirmed in the MPA studies for preventive oncology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. A. G. Panossian, T. Efferth, A. N. Shikov, et al., Med. Res. Rev., 41, 630 – 703 (2021); https://doi.org/10.1002/med.21743.

  2. O. A. Bocharova, R. V. Karpova, E. V. Bocharov, et al., Ross. Bioterapevticheskii Zh., 19(2), 13 (2020).

    Google Scholar 

  3. O. A. Bocharova, R. V. Karpova, E. V. Bocharov, et al., Ross. Bioterapevticheskii Zh., 19(3), 12 (2020).

    Google Scholar 

  4. O. A. Bocharova, M. I. Davydov, A. Yu. Baryshnikov, et al., Vestn. Ross. Akad. Med. Nauk, No. 8 (21), (2009).

  5. E. L. Al?perina, E. V. Bocharov, O. A. Bocharova, et al., Critical Problems of Neuroimmunopathology [in Russian], G. N. Kryzhanovskii, et al., (eds.), Genius Media, Moscow (2012).

  6. A. Panossian, G. Wikman, and J. Sarris, Phytomedicine, 17(7), 481 (2010).

    Article  CAS  PubMed  Google Scholar 

  7. A. N. Shikov, O. N. Pozharitskaya, V. G. Makarov, et al., J. Ethnopharmacol., 154(3), 481 (2014).

    Article  PubMed  Google Scholar 

  8. O. A. Bocharova, R. V. Karpova, E. V. Bocharov, et al., Ross. Bioterapevticheskii Zh., 19(4), 35 (2020).

    Google Scholar 

  9. O. Bocharova, R. Serebriakova, T. Philippova, et al., Farm. Vestn. (Ljublana, Slov.), 48 (Spec. Iss.), 414 (2014).

  10. O. A. Bocharova, M. M. Pozharitskaya, T. L. Chekalina, et al., Bull. Exp. Biol. Med., 138(6), 578 (2004).

    Article  CAS  PubMed  Google Scholar 

  11. E. V. Bocharov, V. G. Kucheryanu, G. N. Kryzhanovsky, et al., Bull. Exp. Biol. Med., 141(5), 560 (2006); E. V. Bocharov, V. G. Kucheryanu, G. N. Kryzhanovskii, et al., Byull. Eksp. Biol. Med., 141(5), 495 – 498 (2006).

  12. O. A. Bocharova, M. I. Davydov, A. A. Klimenkov, et al., Byull. Eksp. Biol. Med., 148(7), 96 (2009).

    Google Scholar 

  13. O. A. Bocharova, M. A. Lyzhenkova, M. V. Mezentseva, et al., Byull. Eksp. Biol. Med., 136(12), 670 (2003).

    Google Scholar 

  14. N. P. Bochkov, O. A. Bocharova, A. A. Akseonv, et al., Med. Genet., 4(1), 15 (2005).

    Google Scholar 

  15. O. A. Bocharova, V. B. Matveev, R. V. Karpova, et al., Bull. Exp. Biol. Med., 141(5), 616 (2006); O. A. Bocharova, V. B. Matveev, R. V. Karpova, et al., Byull. Eksp. Biol. Med., 141(5), 555 – 558 (2006).

  16. O. N. Kurennaya, R. V. Karpova, O. A. Bocharova, et al., Russ. J. Genet., 49(12), 1190 (2013); O. N. Kurennaya, R. V. Karpova, O. A. Bocharova, et al., Genetika (Moscow), 49(12), 1364 – 1369 (2013).

  17. E. V. Bocharov, R. V. Karpova, I. V. Kazeev, et al., Patol. Fiziol. Eksp. Ter., No. 3, 55 (2013).

  18. R. V. Karpova, E. V. Bocharov, I. V. Kazeev, et al., Patol. Fiziol. Eksp. Ter., No. 4, 51 (2013).

  19. V. I. Sheichenko, O. A. Bocharova, O. P. Sheichenko, et al., Zavod. Lab., Diagn. Mater., 72(8), 15 (2006).

  20. O. P. Sheichenko, O. A. Bocharova, V. I. Sheichenko, et al., Vopr. Biol., Med. Farm. Khim., 5(2), 20 (2007).

  21. O. P. Sheichenko, O. A. Bocharova, B. A. Krapivkin, et al., Vopr. Biol., Med. Farm. Khim., No. 10, 52 (2012).

  22. I. V. Kazeev, O. A. Bocharova, V. E. Shevchenko, et al., Teor. Osn. Khim. Tekhnol., 55(6), 780 (2021).

    Google Scholar 

  23. I. V. Kazeev, O. A. Bocharova, V. E. Shevchenko, et al., Teor. Osn. Khim. Tekhnol., 54(6), 733 (2020).

    Google Scholar 

  24. O. A. Bocharova, I. V. Kazeev, V. E. Shevchenko, et al., Khim.-farm. Zh., 56(1), 32 – 38 (2022); Pharm. Chem. J., 56(1), 78 – 84 (2022).

  25. O. A. Bocharova, V. E. Shevchenko, I. V. Kazeev, et al., Khim.-farm. Zh., 56(6), 29 – 37 (2022); Pharm. Chem. J., 56(6), 806 – 814 (2022).

  26. O. A. Bocharova, I. V. Kazeev, N. S. Ionov, et al., Cardiometry.

  27. A. G. Elenevskii, M. P. Solov’eva, and V. N. Tikhomirov, Botany. Systematics of Higher or Terrestrial Plants [in Russian], Akademiya, Moscow (2004).

  28. D. A. Filimonov, D. S. Druzhilovskiy, A. A. Lagunin, et al., Biomed. Chem.: Res. Methods, 1(1), e00004-e00004 (2018).

  29. V. V. Poroikov, Biochemistry (Moscow), Suppl. Ser. B: Biomed. Chem., 14(3), 216 – 227 (2020); V. V. Poroikov, Biomed. Khim., 66(1), 30 – 41 (2020).

  30. A. Dalby, J. G. Nourse, E. D. Hounshell, et al., J. Chem. Inf. Comput. Sci., 32(3), 244 – 255 (1992); https://doi.org/10.1021/ci00007a012.

  31. A. A. Lagunin, R. K. Goel, D. Y. Gawande, et al., Nat. Prod. Rep., 31(11), 1585 – 1611 (2014).

    Article  CAS  PubMed  Google Scholar 

  32. Y. Y. Chen, Q. P. Liu, P. An, et al., Phytomedicine, 95, Art. 153883 (2022); https://doi.org/10.1016/j.phymed.2021.153883.

  33. X. Zhang, X. Liu, G. Hu, et al., NeuroReport, 31(6), 466 – 472 (2020).

    Article  PubMed  Google Scholar 

  34. X. Zhang, Y. Wang, C. Ma, et al., Am. J. Neurodegener. Dis., 5(1), 52 – 61 (2016).

    CAS  PubMed  PubMed Central  Google Scholar 

  35. I. Madhi, J. H. Kim, J. E. Shin, et al., Mol. Med. Rep., 24(4), 698 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. H. Wang, J. Lv, N. Jiang, et al., Phytother. Res., Mar 29 (2021); https://doi.org/10.1002/ptr.6947.

  37. G.-M. Liu, T.-C. Lu, M.-L. Sun, et al., Biol. Pharm. Bull., 43(10), 1534 – 1541 (2020); https://doi.org/10.1248/bpb.b20-00338.

    Article  CAS  PubMed  Google Scholar 

  38. X. Yang, M. Gao, M. Miao, et al., J. Pharm. Pharmacol., 73(2), 263 – 271 (2021); https://doi.org/10.1093/jpp/rgaa006.

  39. E. Zhang, H. Shi, L. Yang, et al., Oncol. Rep., 38(1), 359 – 367 (2017); https://doi.org/10.3892/or.2017.5652.

    Article  CAS  Google Scholar 

  40. Y. Nam, M. B. Wie, E. J. Shi, et al., J. Appl. Toxicol., 35(8), 927 – 944 (2015); https://doi.org/10.1002/jat.3093.

  41. C. Liang, Y. Ding, H. T. Nguyen, et al., Bioorg. Med. Chem. Lett., 20(23), 7110 – 7115 (2010); https://doi.org/10.1016/j.bmcl.2010.09.074.

    Article  CAS  Google Scholar 

  42. N. X. Nhiem, H. Y. Lim, P. V. Kiem, et al., Bioorg. Med. Chem. Lett., 21(20), 6143 – 6147 (2011); https://doi.org/10.1016/j.bmcl.2011.08.024.

    Article  CAS  Google Scholar 

  43. T. Yokozawa, A. Satoh, and E. J. Cho, J. Pharm. Pharmacol., 56(1), 107 – 113 (2004); https://doi.org/10.1211/0022357022449.

  44. J. Li, Z.-Z. Xie, Y.-B. Tang, et al., Eur. J. Pharmacol., 652(1 – 3), 104 – 110 (2011); https://doi.org/10.1016/j.ejphar.2010.11.017.

    Article  CAS  PubMed  Google Scholar 

  45. Y. Luo, S. Lu, Y. Gao, et al., Aging (N. Y.), 12(2), 1704 – 1724 (2020); https://doi.org/10.18632/aging.102708.

  46. H. Wang, Y. Teng, S. Li, et al., Molecules, 26(21), 6657 (2021); https://doi.org/10.3390/molecules26216657.

  47. R. Ye, J. Han, X. Kong, et al., Biol. Pharm. Bull., 31(10), 1923 – 1927 (2008); https://doi.org/10.1248/bpb.31.1923.

    Article  CAS  PubMed  Google Scholar 

  48. X.-Y. Gao, G.-C. Liu, J.-X. Zhang, et al., Front. Pharmacol., 13, 754191 (2022); https://doi.org/10.3389/fphar.2022.754191.

  49. G. H. Lee, W. J. Lee, J. Hur, et al., Molecules, 25(1), 188 (2020); https://doi.org/10.3390/molecules25010188.

  50. X. Su, Z. Pei, and S. Hu, Int. Immunopharmacol., 20(2), 283 – 289 (2014); https://doi.org/10.1016/j.intimp.2014.03.008.

    Article  CAS  PubMed  Google Scholar 

  51. M. Wang, R. Wang, X. Xie, et al., Biomed. Pharmacother., 117, 109143 (2019); https://doi.org/10.1016/j.biopha.2019.109143.

  52. Y. Ding, Q. Zhao, and L. Wang, Chem.-Biol. Interact., 306, 131 – 137 (2019); https://doi.org/10.1016/j.cbi.2019.04.025.

  53. H. He, X. Li, H. Yu, et al., J. Nat. Med., 73(2), 339 – 352 (2019); https://doi.org/10.1007/s11418-018-1256-0.

  54. H. Sun, S. Ling, D. Zhao, et al., Front. Pharmacol., 11, 532041 (2020); https://doi.org/10.3389/fphar.2020.532041.

  55. M. Wang, R. Wang, X. Xie, G. Sun, et al., Biomed. Pharmacother., 117, 109143 (2019); https://doi.org/10.1016/j.biopha.2019.109143.

  56. J. Wang, X. Li, G. Peng, et al., Evidence-Based Complementary Altern. Med., 2022, 2056630 (2022); https://doi.org/10.1155/2022/2056630.

  57. O. A. Bocharova, R. V. Karpova, V. A. Golubeva, et al., Byull. Eksp. Biol. Med., 128(10), 403 – 407 (1999).

    CAS  Google Scholar 

  58. O. A. Bocharova, A. Yu. Baryshnikov, and M. I. Davydov, Phytoadaptogens in Oncology and Gerontology [in Russian], MIA, Moscow (2008).

    Google Scholar 

  59. O. A. Bocharova, R. V. Karpova, V. B. Matveev, et al., Ross. Bioterapevticheskii Zh., 3(1), 90 – 95 (2004).

    Google Scholar 

  60. E. V. Bocharov, I. A. Ivanova-Smolenskaya, V. V. Poleshchuk, et al., Byull. Eksp. Biol. Med., 149(6), 619 – 621 (2010).

    Article  Google Scholar 

  61. E. V. Bocharov, O. A. Bocharova, Yu. N. Solov’ev, et al., Byull. Eksp. Biol. Med., 161(5), 674 – 677 (2016).

  62. E. V. Bocharov, O. A. Bocharova, R. V. Karpova, et al., Ross. Bioterapevticheskii Zh., 17(2), 69 – 78 (2018).

    Google Scholar 

  63. O. A. Bocharova, A. V. Revishchin, E. V. Bocharov, et al., Lab. Zhivotn. Nauchn. Issled., No. 2, 47 – 53 (2021).

  64. O. A. Bocharova, E. V. Bocharov, V. G. Kucheryanu, et al., Ross. Bioterapevticheskii Zh., 18(4), 25 – 33 (2019).

    Google Scholar 

  65. O. A. Bocharova, E. V. Bocharov, R. V. Karpova, et al., Byull. Eksp. Biol. Med., 157(2), 223 – 226 (2014).

    Article  Google Scholar 

  66. E. V. Bocharov, R. V. Karpova, A. A. Vershinskaya, et al., Ross. Bioterapevticheskii Zh., 14(2), 85 – 90 (2015).

    Google Scholar 

  67. O. A. Bocharova and A. Yu. Baryshnikov, Phytoadaptogens in Oncology [in Russian], ZooMedVet, Moscow (2004).

    Google Scholar 

  68. M. M. Pozharitskaya, O. A. Bocharova, T. L. Chekalina, et al., Modern Aspects of Pathogenesis and Treatment of Leukoplakia of Oral Cavity Mucous Membrane [in Russian], Moscow (2004).

Download references

Acknowledgments

The work was performed in the framework of the Basic Scientific Research Program in the Russian Federation for the long-term (2021 – 2030) (No. 122030100170-5) and with support in part by grants from the Commission on Biomedical Innovations and Technologies of the Ministry of Science and Higher Education of the Russian Federation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. V. Kazeev.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 1, pp. 29 – 36, January, 2023.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kazeev, I.V., Ionov, N.S., Shevchenko, V.E. et al. Secondary Metabolites of Oplopanax elatus: Possibilities for Standardization of a Multiphytoadaptogen for Preventive Oncology. Pharm Chem J 57, 75–82 (2023). https://doi.org/10.1007/s11094-023-02853-w

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-023-02853-w

Keywords

Navigation